Muxin Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muxin Yu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jinming Zhang
Department of Gastroenterology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China
4 shared publications Chuwei Zheng
Department of Gastroenterology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314000, China
3 shared publicationsXiaowen Li
Department of Pathology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314000, China
3 shared publicationsXia Ji
Department of Gastroenterology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314000, China
2 shared publications- Chuwei Zheng
Department of Gastroenterology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China
1 shared publication - Guocheng Zeng
Zhejiang Chinese Medical University, Hangzhou, 310000, China; Department of Gastroenterology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314000, China
1 shared publication
Latest Publications
- 28 January 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 804, 153356
Mitochondrial dysfunction in MASH: Focusing on chronic inflammation and intercellular communication
- 28 January 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 804, 153356
Mitochondrial dysfunction in MASH: Focusing on chronic inflammation and intercellular communication
- 16 June 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 102 (6) , 916-917
A rare case of urachal cyst in the ascending colon of an adult patient
- 16 June 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 102 (6) , 916-917
A rare case of urachal cyst in the ascending colon of an adult patient
- 7 February 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 102 (1) , 146-147
A rare case of gastric mass due to adrenal tuberculosis presenting without typical clinical manifestations of Addison’s disease
- 7 February 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 102 (1) , 146-147
A rare case of gastric mass due to adrenal tuberculosis presenting without typical clinical manifestations of Addison’s disease
- Open Access
- 1 August 2024
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (8)
Neutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease
Background: Cholestatic liver diseases induce local and systemic hypercoagulation, with neutrophil extracellular traps (NETs) serving as major drivers. These NETs have been linked to decreased liver function in patients with obstructive jaundice. However, the impact of NETs on liver hypercoagulation in cholestatic liver disease remains unknown. Methods: We utilized bile duct ligation to create experimental mice and analyzed NETs formation in the liver. Fibrin deposition, tissue factor expression, and inflammation in the liver were visualized through western blot and immunohistochemical techniques. LSECs were incubated with isolated NETs, and we detected endothelial procoagulant activity using coagulation protein production assays and measuring endothelial permeability. In both in vivo and in vitro settings, DNase I was applied to clarify the effect of NETs on intrahepatic hypercoagulability, hepatotoxicity, LSEC, and macrophage activation or injury. Results: Bile duct ligation mice exhibited significantly increased levels of NETs in liver tissue, accompanied by neutrophil infiltration, tissue necrosis, fibrin deposition, and thrombophilia compared to sham mice. Notably, NETs resulted in phosphatidylserine and tissue factor exposure on LSEC, enhancing coagulation Factor Xa and thrombin production. The enhanced procoagulant activity could be reversed by degrading NETs with DNase I. Additionally, NETs-induced permeability changes in LSECs, characterized by increased VE-cadherin expression and F-actin retraction, which could be rescued by DNase I. Meanwhile, NET formation is associated with KC activation and the formation of inflammatory factors. Conclusions: NETs promote intrahepatic activation of coagulation and inflammation, leading to liver tissue injury. Strategies targeting NET formation may offer a potential therapeutic approach for treating cholestatic liver disease.
- 1 August 2024
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (8)
Open AccessNeutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease
Background: Cholestatic liver diseases induce local and systemic hypercoagulation, with neutrophil extracellular traps (NETs) serving as major drivers. These NETs have been linked to decreased liver function in patients with obstructive jaundice. However, the impact of NETs on liver hypercoagulation in cholestatic liver disease remains unknown. Methods: We utilized bile duct ligation to create experimental mice and analyzed NETs formation in the liver. Fibrin deposition, tissue factor expression, and inflammation in the liver were visualized through western blot and immunohistochemical techniques. LSECs were incubated with isolated NETs, and we detected endothelial procoagulant activity using coagulation protein production assays and measuring endothelial permeability. In both in vivo and in vitro settings, DNase I was applied to clarify the effect of NETs on intrahepatic hypercoagulability, hepatotoxicity, LSEC, and macrophage activation or injury. Results: Bile duct ligation mice exhibited significantly increased levels of NETs in liver tissue, accompanied by neutrophil infiltration, tissue necrosis, fibrin deposition, and thrombophilia compared to sham mice. Notably, NETs resulted in phosphatidylserine and tissue factor exposure on LSEC, enhancing coagulation Factor Xa and thrombin production. The enhanced procoagulant activity could be reversed by degrading NETs with DNase I. Additionally, NETs-induced permeability changes in LSECs, characterized by increased VE-cadherin expression and F-actin retraction, which could be rescued by DNase I. Meanwhile, NET formation is associated with KC activation and the formation of inflammatory factors. Conclusions: NETs promote intrahepatic activation of coagulation and inflammation, leading to liver tissue injury. Strategies targeting NET formation may offer a potential therapeutic approach for treating cholestatic liver disease.